Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7579321 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
May, 2023
(28 days ago) | |
US7405203 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
May, 2023
(28 days ago) | |
US7799761 | SERENITY PHARMS LLC | Pharmaceutical compositions including low dosages of desmopressin |
Sep, 2024
(1 year, 3 months from now) | |
US9539302 | SERENITY PHARMS LLC | Safe desmopressin administration |
Jun, 2030
(7 years from now) | |
US11419914 | SERENITY PHARMS LLC | Safe desmopressin administration |
Jun, 2030
(7 years from now) |
Drugs and Companies using DESMOPRESSIN ACETATE ingredient
Market Authorisation Date: 03 March, 2017
Treatment: A method of treating nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void by inducing an antidiuretic e...
Dosage: SPRAY, METERED;NASAL
26
United States
8
Australia
8
Japan
7
European Union
6
China
5
Korea, Republic of
5
Denmark
5
Spain
4
Portugal
4
Poland
3
Canada
3
Russia
3
Mexico
3
Argentina
3
Brazil
2
EA
2
Israel
2
IB
2
New Zealand
2
Uruguay
2
Singapore
2
Germany
2
South Africa
1
Croatia
1
Malaysia
1
Austria
1
Ukraine
1
Norway
1
United Kingdom
1
Hong Kong
1
Slovenia
1
Taiwan
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic